Evidence map›Paper›PMID 40493875›Full record

ArticleNeurology2025

Nicotine, Alcohol Consumption, and Risk of Myasthenia Gravis: Results From the Swedish Nationwide GEMG Study.

Malin Petersson, Daniel Jons, Amalia Feresiadou, Andreea Ilinca, Fredrik Lundin, Rune Johansson, Anna Budzianowska, Anna-Karin Roos, Viktor Kagstrom, Martin Gunnarsson and 7 more

Abstract read
In one paragraph

Article in Neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Malin PeterssonDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-3449-0429
Daniel JonsDepartment of Clinical Neuroscience, Institute of Neuroscience and Physiology, the Sahlgrenska Academy, University of Gothenburg, Sweden.
Amalia FeresiadouDepartment of Neuroscience, Neurology, Uppsala University, Sweden.
Andreea IlincaDepartment of Neurology, Skåne University Hospital, Malmö, Sweden.
Fredrik LundinDepartment of Neurology and Department of Biomedical and Clinical Sciences, Division of Neurobiology, Linköping University, Sweden.ORCID 0000-0003-3916-198X
Rune JohanssonDepartment of Neurology and Rehabilitation, Karlstad Central Hospital, Sweden.
Anna BudzianowskaDepartment of Neurology, Ryhov Hospital, Jönköping, Sweden.
Anna-Karin RoosUnit of Neurology, Department of Clinical Science, Neurosciences, Umeå University, Östersund, Sweden.
Viktor KagstromRehabilitation Clinic, Sundsvall Hospital, Sweden.
Martin GunnarssonDepartment of Neurology, Faculty of Medicine and Health, Örebro University, Sweden.
Peter SundströmDepartment of Clinical Sciences, Neurosciences, Umeå University, Sweden.
Lars KlareskogDepartment of Medicine, Karolinska Institutet, Stockholm, Sweden.
Tomas OlssonDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-2938-1877
Ingrid KockumDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-0867-4726
Fredrik PiehlDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0001-8329-5219
Lars AlfredssonInstitute for Environmental Medicine, Karolinska Institute, Stockholm, Sweden.ORCID 0000-0003-1688-6697
Susanna BraunerDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-9120-9488

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesMyasthenia gravis (MG), an autoimmune disease characterized by fluctuating muscle weakness, is believed to result from complex gene-environment interactions, yet few risk factors have been identified. The objective of this study was to determine the effect of nicotine and alcohol on MG disease risk.

methodsThe Genes and Environment in Myasthenia Gravis study is a Swedish, nationwide cross-sectional case-control study where prevalent patients with MG were invited to submit an extensive questionnaire on lifestyle and environment. Data collection took place between November 2018 and August 2019, and cases were matched by sex and year of birth to population controls. Year of disease onset was used as index year. Associations between use of alcohol, tobacco smoke, Swedish snuff, and MG risk were investigated using multivariable logistic regression.

resultsA total of 1,067 patients with MG (mean age at onset 48 (SD 21) years, 53% female) were matched to 2,087 controls. Any alcohol consumption was associated with a lower MG risk compared with not drinking at all (odds ratio [OR] 0.48, 95% CI 0.39-0.59, DISCUSSION: We observed an inverse correlation of MG risk and alcohol consumption. Furthermore, smoking and the use of Swedish snuff at disease onset were positively associated with EOMG. We recognize limitations related to retrospective data and limited number of available controls. However, multiple sensitivity analyses were performed supporting the robustness of our results.

Indexed as

Alcohol DrinkingMyasthenia GravisNicotineAdultAgedCase-Control StudiesCross-Sectional StudiesFemaleHumansMaleMiddle AgedRisk FactorsSwedenTobacco, SmokelessNicotine

Identifiers

PMID40493875
PMCPMC12165285

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.